These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23811027)

  • 1. Correlation of Aβ oligomer levels in matched cerebrospinal fluid and serum samples.
    Kasai T; Tokuda T; Taylor M; Kondo M; Mann DM; Foulds PG; Nakagawa M; Allsop D
    Neurosci Lett; 2013 Sep; 551():17-22. PubMed ID: 23811027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients.
    Fukumoto H; Tokuda T; Kasai T; Ishigami N; Hidaka H; Kondo M; Allsop D; Nakagawa M
    FASEB J; 2010 Aug; 24(8):2716-26. PubMed ID: 20339023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of a multiple antigenic peptide as a calibration standard in the BAN50 single antibody sandwich ELISA for Aβ oligomers.
    Kasai T; Tokuda T; Taylor M; Nakagawa M; Allsop D
    Biochem Biophys Res Commun; 2012 Jun; 422(3):375-80. PubMed ID: 22580285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-β oligomer detection by ELISA in cerebrospinal fluid and brain tissue.
    Bruggink KA; Jongbloed W; Biemans EA; Veerhuis R; Claassen JA; Kuiperij HB; Verbeek MM
    Anal Biochem; 2013 Feb; 433(2):112-20. PubMed ID: 23022042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-β oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer's disease.
    Santos AN; Ewers M; Minthon L; Simm A; Silber RE; Blennow K; Prvulovic D; Hansson O; Hampel H
    J Alzheimers Dis; 2012; 29(1):171-6. PubMed ID: 22214781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The amyloid-β oligomer count in cerebrospinal fluid is a biomarker for Alzheimer's disease.
    Wang-Dietrich L; Funke SA; Kühbach K; Wang K; Besmehn A; Willbold S; Cinar Y; Bannach O; Birkmann E; Willbold D
    J Alzheimers Dis; 2013; 34(4):985-94. PubMed ID: 23313925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sensitive aβ oligomer assay discriminates Alzheimer's and aged control cerebrospinal fluid.
    Savage MJ; Kalinina J; Wolfe A; Tugusheva K; Korn R; Cash-Mason T; Maxwell JW; Hatcher NG; Haugabook SJ; Wu G; Howell BJ; Renger JJ; Shughrue PJ; McCampbell A
    J Neurosci; 2014 Feb; 34(8):2884-97. PubMed ID: 24553930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity and sensitivity of the Abeta oligomer ELISA.
    Klaver AC; Patrias LM; Finke JM; Loeffler DA
    J Neurosci Methods; 2011 Feb; 195(2):249-54. PubMed ID: 21163305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference from heterophilic antibodies in amyloid-β oligomer ELISAs.
    Sehlin D; Söllvander S; Paulie S; Brundin R; Ingelsson M; Lannfelt L; Pettersson FE; Englund H
    J Alzheimers Dis; 2010; 21(4):1295-301. PubMed ID: 21504116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease.
    Xia W; Yang T; Shankar G; Smith IM; Shen Y; Walsh DM; Selkoe DJ
    Arch Neurol; 2009 Feb; 66(2):190-9. PubMed ID: 19204155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
    Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
    Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The load of amyloid-β oligomers is decreased in the cerebrospinal fluid of Alzheimer's disease patients.
    Sancesario GM; Cencioni MT; Esposito Z; Borsellino G; Nuccetelli M; Martorana A; Battistini L; Sorge R; Spalletta G; Ferrazzoli D; Bernardi G; Bernardini S; Sancesario G
    J Alzheimers Dis; 2012; 31(4):865-78. PubMed ID: 22717612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No correlation between time-linked plasma and CSF Abeta levels.
    Le Bastard N; Aerts L; Leurs J; Blomme W; De Deyn PP; Engelborghs S
    Neurochem Int; 2009 Dec; 55(8):820-5. PubMed ID: 19695299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of two antibodies to oligomeric Abeta and their use in ELISAs on human brain tissue homogenates.
    van Helmond Z; Heesom K; Love S
    J Neurosci Methods; 2009 Jan; 176(2):206-12. PubMed ID: 18824027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF.
    Yang T; Hong S; O'Malley T; Sperling RA; Walsh DM; Selkoe DJ
    Alzheimers Dement; 2013 Mar; 9(2):99-112. PubMed ID: 23375565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation of β-amyloid from lipoprotein in cerebrospinal fluid from Alzheimer's disease accelerates β-amyloid-42 assembly.
    Takamura A; Kawarabayashi T; Yokoseki T; Shibata M; Morishima-Kawashima M; Saito Y; Murayama S; Ihara Y; Abe K; Shoji M; Michikawa M; Matsubara E
    J Neurosci Res; 2011 Jun; 89(6):815-21. PubMed ID: 21394760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced levels of amyloid beta-peptide antibody in Alzheimer disease.
    Du Y; Dodel R; Hampel H; Buerger K; Lin S; Eastwood B; Bales K; Gao F; Moeller HJ; Oertel W; Farlow M; Paul S
    Neurology; 2001 Sep; 57(5):801-5. PubMed ID: 11552007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings.
    Seppälä TT; Nerg O; Koivisto AM; Rummukainen J; Puli L; Zetterberg H; Pyykkö OT; Helisalmi S; Alafuzoff I; Hiltunen M; Jääskeläinen JE; Rinne J; Soininen H; Leinonen V; Herukka SK
    Neurology; 2012 May; 78(20):1568-75. PubMed ID: 22517093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anomalously phosphorylated tau and Abeta fragments in the CSF correlates with cognitive impairment in MCI subjects.
    Maccioni RB; Lavados M; Guillón M; Mujica C; Bosch R; Farías G; Fuentes P
    Neurobiol Aging; 2006 Feb; 27(2):237-44. PubMed ID: 16399209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.